Vangipuram Rangan
Vice President: Protein Sciences & Early CMC at CytomX Therapeutics | San Francisco Bay Area
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Vice President: Protein Sciences & Early CMC at CytomX Therapeutics in October 2023 to Present
Executive Director, Protein Sciences & Early CMC at CytomX Therapeutics in April 2021 to October 2023
Senior Director, Protein Sciences at CytomX Therapeutics in October 2018 to April 2021
Senior Director, Protein Chemistry at Bristol-Myers Squibb in October 2009 to October 2018
Director at Medarex in December 2001 to September 2009
Associate Scientist at Children's Hospital Oakland Research Institute in January 1989 to January 2001
See more
See less
University of Mysore, PhD, January 1983 to January 1988
See more
See less
Strategic Thinking
Record Of Success
Build Strong Relationships
Regulatory Requirements
Communication
Interpersonal Skills
Leadership
Protein Chemistry
Drug Development
Antibodies
Biotechnology
Molecular Biology
Characterization
Assay Development
Drug Discovery
Protein Purification
Immunology
Pharmaceutical Industry
Cell Culture
Life Sciences
Biopharmaceuticals
Cell Biology
Oncology
ELISA
High-Performance Liquid Chromatography (HPLC)
Chromatography
In Vitro
Chemistry
Real-Time Polymerase Chain Reaction (qPCR)
Liquid Chromatography-Mass Spectrometry (LC-MS)
Cancer Immunotherapy
Protein Characterization
Tumor Immunology
See more
See less
Discover more about CytomX TherapeuticsWhat is Vangipuram Rangan email address?
Email Vangipuram Rangan at [email protected] and [email protected]. This email is the most updated Vangipuram Rangan's email found in 2026.
How to contact Vangipuram Rangan?
To contact Vangipuram Rangan send an email to [email protected] or [email protected].
What company does Vangipuram Rangan work for?
Vangipuram Rangan works for CytomX Therapeutics
What is Vangipuram Rangan's role at CytomX Therapeutics?
Vangipuram Rangan is Vice President: Protein Sciences & Early CMC
What is Vangipuram Rangan's Phone Number?
Vangipuram Rangan's phone (**) *** *** 422
What industry does Vangipuram Rangan work in?
Vangipuram Rangan works in the Biotechnology industry.
Vangipuram Rangan Email Addresses
Vangipuram Rangan Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Vangipuram Rangan
Healthcare Technology/Opportunity Reviewer at Band of Angels
Vice President, Portfolio & Alliance Management at CytomX Therapeutics
Associate Scientist at CytomX Therapeutics
Executive Director, Clinical Operations at CytomX Therapeutics
Chief Executive Officer and Director at Biological Dynamics
Sr. Director of Business Development at Culture Biosciences
President at HARVEST FOR THE HUNGRY INC
Founder & CTO at Meenta
Co-Founder & Partner at Initiate Studios
Vice President Information Technology at Aspen Surgical
General Manager at Powdersville Water
Receiving Manager at Jason's Deli Distribution
Owner at Drive in Motors LLC
Store Manager at Kroger
Speechwriter at United States Southern Command
Cashier at Godfather's Pizza
Founder & Principal at Trailhead Management Consulting Services
Manager of Finance and Operations at San Mateo County Community College District
Executive Editor at Andrews McMeel Publishing
Licensed Mortician/Office Manager at Mundwiler & Larson Funeral Home
Strategic Advisor at Quantitative Scientific Solutions
Co-Founder and Managing Director at Aditum Bio
Assistente Financeiro at NET Serviços de Comunicação S/A
Global Head of Corporate Social Responsibility at Moody's Corporation
Show more
Show less